000			01963nam a2200397 a 4500
001			EBC818637
003			MiAaPQ
005			20240120133023.0
006			m o d |
007			cr cn|||||||||
008			100616s2011 njua sb 001 0 eng d
010			_z 2010025372
020			_z9780470455630 (cloth)
020			_z9780470929353 (oBook)
020			_a9780470934685 (electronic bk.)
020			_a9780470929346 (electronic bk.)
035			_a(MiAaPQ)EBC818637
035			_a(Au-PeEL)EBL818637
035			_a(CaPaEBR)ebr10490613
035			_a(CaONFJC)MIL320363
035			_a(OCoLC)746598445
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRM411 _b.A5753 2011
082	0	4	_a615/.7924 _222
245	0	0	_aAntiviral drugs _h[electronic resource] : _bfrom basic discovery through clinical trials / _cedited by Wieslaw M. Kazmierski.
260			_aHoboken, N.J. : _bWiley, _cc2011.
300			_axiii, 438 p. : _bill. (some col.)
504			_aIncludes bibliographical references and index.
505	0		_apt. 1. Human immunodeficiency virus. section 1. HIV protease inhibitors ; section 2. HIV non-nucleoside reverse transcriptase inhibitors ; section 3. HIV nucleoside reverse transcriptase inhibitors ; section 4. HIV entry inhibitors ; section 5. HIV integrase inhibitors -- pt. 2. Hepatitis C virus. section 6. Protease inhibitors ; section 7. HCV polymerase nucleoside inhibitors ; section 8. Other HCV inhibitors -- pt. 3. Respiratory syncytial virus inhibitors -- pt. 4. Influenza, Hepatitis B, and Cytomegalovirus inhibitors.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aAntiviral agents.
655		4	_aElectronic books.
700	1		_aKazmierski, Wieslaw M.
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=818637 _zClick to View
999			_c71951 _d71951